Rise Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-143
Closed -$22.4K – 306
2025
Q3
$22.4K Buy
143
+4
+3% +$618 0.01% 516
2025
Q2
$23.4K Hold
139
– – 0.01% 448
2025
Q1
$19.1K Sell
139
-12
-8% -$1.53K 0.01% 522
2024
Q4
$17.9K Buy
151
+1
+0.7% +$117 0.01% 733
2024
Q3
$16.6K Hold
150
– – 0.01% 806
2024
Q2
$14.7K Buy
150
+1
+0.7% +$102 0.01% 834
2024
Q1
$16.7K Buy
+149
New +$16.1K 0.01% 780
2022
Q1
– Sell
-25
Closed -$1.31K – 656
2021
Q4
$1.31K Buy
+25
New +$1.23K ﹤0.01% 581

Other funds holding CAH

Rise Advisors's CAH Position: Q4 2025 in Review

Rise Advisors sold out of Cardinal Health (CAH) in Q4 2025, closing a stake of 143 shares — an estimated $22.4K sold.

Rise Advisors first reported a position in CAH in Q4 2021 and held it in 8 quarters. The position peaked at $23.4K in Q2 2025. 1,412 funds tracked by Wall St. Rank hold CAH as of Q4 2025.

  • Rise Advisors reported no remaining Cardinal Health position as of Q4 2025 after selling out during the quarter.
  • Rise Advisors sold 143 Cardinal Health shares in Q4 2025, an estimated $22.4K.
  • Rise Advisors first reported a position in Cardinal Health in Q4 2021 and held it in 8 quarters.
  • Rise Advisors's Cardinal Health position peaked at $23.4K in Q2 2025.
  • 1,412 funds tracked by Wall St. Rank held Cardinal Health as of Q4 2025.

Based on Rise Advisors's 13F filing for Q4 2025, filed 11 Feb 2026.